Overview

NPIL has APIs & Intermediates manufacturing facilities located at Hyderabad and Chennai. The Hyderabad plant has facility approval by USFDA (without any 483s) while the Chennai facility is a cGMP compliant site dedicated for the manufacture of advanced intermediates.  The Hyderabad facility is also approved by MHRA, TGA and WHO.

Finished dosage formulations for CMG are manufactured at Pithampur (MP) plant which is approved by MHRA, SA MCC and TGA.